Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study

Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C, Alsharif U, Alvis-Guzman N, Amini E, Anderson BO, Aremu O, et al. (2018)
JAMA Oncology 4(11): 1553-1568.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Fitzmaurice, Christina; Akinyemiju, Tomi F.; Al Lami, Faris Hasan; Alam, Tahiya; Alizadeh-Navaei, Reza; Allen, Christine; Alsharif, Ubai; Alvis-Guzman, Nelson; Amini, Erfan; Anderson, Benjamin O.; Aremu, Olatunde; Artaman, Al
Alle
Abstract / Bemerkung
IMPORTANCE The increasing burden due to cancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) Global Action Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. OBJECTIVE To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. EVIDENCE REVIEW Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. FINDINGS In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallest increase was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause of cancer deaths and DALYs was breast cancer (1.7 million incident cases, 535 000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. CONCLUSIONS AND RELEVANCE Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.
Erscheinungsjahr
2018
Zeitschriftentitel
JAMA Oncology
Band
4
Ausgabe
11
Seite(n)
1553-1568
Konferenz
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Konferenzort
Chicago, IL
ISSN
2374-2437
eISSN
2374-2445
Page URI
https://pub.uni-bielefeld.de/record/2932789

Zitieren

Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology . 2018;4(11):1553-1568.
Fitzmaurice, C., Akinyemiju, T. F., Al Lami, F. H., Alam, T., Alizadeh-Navaei, R., Allen, C., Alsharif, U., et al. (2018). Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology , 4(11), 1553-1568. doi:10.1001/jamaoncol.2018.2706
Fitzmaurice, Christina, Akinyemiju, Tomi F., Al Lami, Faris Hasan, Alam, Tahiya, Alizadeh-Navaei, Reza, Allen, Christine, Alsharif, Ubai, et al. 2018. “Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study”. JAMA Oncology 4 (11): 1553-1568.
Fitzmaurice, C., Akinyemiju, T. F., Al Lami, F. H., Alam, T., Alizadeh-Navaei, R., Allen, C., Alsharif, U., Alvis-Guzman, N., Amini, E., Anderson, B. O., et al. (2018). Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology 4, 1553-1568.
Fitzmaurice, C., et al., 2018. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology , 4(11), p 1553-1568.
C. Fitzmaurice, et al., “Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study”, JAMA Oncology , vol. 4, 2018, pp. 1553-1568.
Fitzmaurice, C., Akinyemiju, T.F., Al Lami, F.H., Alam, T., Alizadeh-Navaei, R., Allen, C., Alsharif, U., Alvis-Guzman, N., Amini, E., Anderson, B.O., Aremu, O., Artaman, A., Asgedom, S.W., Assadi, R., Atey, T.M., Avila-Burgos, L., Awasthi, A., Saleem, H.O.B., Barac, A., Bennett, J.R., Bensenor, I.M., Bhakta, N., Brenner, H., Cahuana-Hurtado, L., Castaneda-Orjuela, C.A., Castaneda-Orjuela, C.A., Catala-Lopez, F., Choi, J.-Y.J., Christopher, D.J., Chung, S.-C., Curado, M.P., Dandona, L., Dandona, R., das Neves, J., Dey, S., Dharmaratne, S.D., Doku, D.T., Driscoll, T., Dubey, M., Ebrahimi, H., Edessa, D., El-Khatib, Z., Endries, A.Y., Fischer, F., Force, L.M., Foreman, K.J., Gebrehiwot, S.W., Gopalani, S.V., Grosso, G., Gupta, R., Gyawali, B., Hamadeh, R.R., Hamidi, S., Harvey, J., Hassen, H.Y., Hay, R.J., Hay, S.I., Heibati, B., Hiluf, M.K., Horita, N., Hosgood, H.D., Ilesanmi, O.S., Innos, K., Islami, F., Jakovljevic, M.B., Johnson, S.C., Jonas, J.B., Kasaeian, A., Kassa, T.D., Khader, Y.S., Khan, E.A., Khan, G., Khang, Y.-H., Khosravi, M.H., Khubchandani, J., Kopec, J.A., Kumar, G.A., Kutz, M., Lad, D.P., Lafranconi, A., Lan, Q., Legesse, Y., Leigh, J., Linn, S., Lunevicius, R., Majeed, A., Malekzadeh, R., Malta, D.C., Mantovani, L.G., McMahon, B.J., Meier, T., Melaku, Y.A., Melku, M., Memiah, P., Mendoza, W., Meretoja, T.J., Mezgebe, H.B., Miller, T.R., Mohammed, S., Mokdad, A.H., Moosazadeh, M., Moraga, P., Mousavi, S.M., Nangia, V., Cuong Tat Nguyen, C.T.N., Vuong Minh Nong, V.M.N., Ogbo, F.A., Olagunju, A.T., Mahesh, P.A., Park, E.-K., Patel, T., Pereira, D.M., Pishgar, F., Postma, M.J., Pourmalek, F., Qorbani, M., Rafay, A., Rawaf, S., Rawaf, D.L., Roshandel, G., Safiri, S., Salimzadeh, H., Sanabria, J.R., Milicevic, M.M.S., Sartorius, B., Satpathy, M., Sepanlou, S.G., Shackelford, K.A., Shaikh, M.A., Sharif-Alhoseini, M., She, J., Shin, M.-J., Shiue, I., Shrime, M.G., Sinke, A.H., Sisay, M., Sligar, A., Sufiyan, M.B., Sykes, B.L., Tabares-Seisdedos, R., Tessema, G.A., Topor-Madry, R., Tung Thanh Tran, T.T.T., Bach Xuan Tran, B.X.T., Ukwaja, K.N., Vlassov, V.V., Vollset, S.E., Weiderpass, E., Williams, H.C., Yimer, N.B., Yonemoto, N., Younis, M.Z., Murray, C.J.L., Naghavi, M.: Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology . 4, 1553-1568 (2018).
Fitzmaurice, Christina, Akinyemiju, Tomi F., Al Lami, Faris Hasan, Alam, Tahiya, Alizadeh-Navaei, Reza, Allen, Christine, Alsharif, Ubai, Alvis-Guzman, Nelson, Amini, Erfan, Anderson, Benjamin O., Aremu, Olatunde, Artaman, Al, Asgedom, Solomon Weldegebreal, Assadi, Reza, Atey, Tesfay Mehari, Avila-Burgos, Leticia, Awasthi, Ashish, Saleem, Huda Omer Ba, Barac, Aleksandra, Bennett, James R., Bensenor, Isabela M., Bhakta, Nickhill, Brenner, Hermann, Cahuana-Hurtado, Lucero, Castaneda-Orjuela, Carlos A., Castaneda-Orjuela, Carlos A., Catala-Lopez, Ferran, Choi, Jee-Young Jasmine, Christopher, Devasahayam Jesudas, Chung, Sheng-Chia, Curado, Maria Paula, Dandona, Lalit, Dandona, Rakhi, das Neves, Jose, Dey, Subhojit, Dharmaratne, Samath D., Doku, David Teye, Driscoll, Timr., Dubey, Manisha, Ebrahimi, Hedyeh, Edessa, Dumessa, El-Khatib, Ziad, Endries, Aman Yesuf, Fischer, Florian, Force, Lisa M., Foreman, Kyle J., Gebrehiwot, Solomon Weldemariam, Gopalani, Sameer Vali, Grosso, Giuseppe, Gupta, Rahul, Gyawali, Bishal, Hamadeh, Randah Ribhi, Hamidi, Samer, Harvey, James, Hassen, Hamid Yimam, Hay, Roderick J., Hay, Simon I., Heibati, Behzad, Hiluf, Molla Kahssay, Horita, Nobuyuki, Hosgood, H. Dean, Ilesanmi, Olayinka S., Innos, Kaire, Islami, Farhad, Jakovljevic, Mihajlo B., Johnson, Sarah Charlotte, Jonas, Jost B., Kasaeian, Amir, Kassa, Tesfaye Dessale, Khader, Yousef Saleh, Khan, Ejaz Ahmad, Khan, Gulfaraz, Khang, Young-Ho, Khosravi, Mohammad Hossein, Khubchandani, Jagdish, Kopec, Jacek A., Kumar, G. Anil, Kutz, Michael, Lad, Deepesh Pravinkumar, Lafranconi, Alessandra, Lan, Qing, Legesse, Yirga, Leigh, James, Linn, Shai, Lunevicius, Raimundas, Majeed, Azeem, Malekzadeh, Reza, Malta, Deborah Carvalho, Mantovani, Lorenzo G., McMahon, Brian J., Meier, Toni, Melaku, Yohannes Adama, Melku, Mulugeta, Memiah, Peter, Mendoza, Walter, Meretoja, Tuomo J., Mezgebe, Haftay Berhane, Miller, Ted R., Mohammed, Shafiu, Mokdad, Ali H., Moosazadeh, Mahmood, Moraga, Paula, Mousavi, Seyyed Meysam, Nangia, Vinay, Cuong Tat Nguyen, Cuong Tat Nguyen, Vuong Minh Nong, Vuong Minh Nong, Ogbo, Felix Akpojene, Olagunju, Andrew Toyin, Mahesh, P. A., Park, Eun-Kee, Patel, Tejas, Pereira, David M., Pishgar, Farhad, Postma, Maarten J., Pourmalek, Farshad, Qorbani, Mostafa, Rafay, Anwar, Rawaf, Salman, Rawaf, David Laith, Roshandel, Gholamreza, Safiri, Saeid, Salimzadeh, Hamideh, Sanabria, Juan Ramon, Milicevic, Milena M. Santric, Sartorius, Benn, Satpathy, Maheswar, Sepanlou, Sadaf G., Shackelford, Katya Anne, Shaikh, Masood Ali, Sharif-Alhoseini, Mahdi, She, Jun, Shin, Min-Jeong, Shiue, Ivy, Shrime, Mark G., Sinke, Abiy Hiruye, Sisay, Mekonnen, Sligar, Amber, Sufiyan, Muawiyyah Babale, Sykes, Bryan L., Tabares-Seisdedos, Rafael, Tessema, Gizachew Assefa, Topor-Madry, Roman, Tung Thanh Tran, Tung Thanh Tran, Bach Xuan Tran, Bach Xuan Tran, Ukwaja, Kingsley Nnanna, Vlassov, Vasiliy Victorovich, Vollset, Stein Emil, Weiderpass, Elisabete, Williams, Hywel C., Yimer, Nigus Bililign, Yonemoto, Naohiro, Younis, Mustafa Z., Murray, Christopher J. L., and Naghavi, Mohsen. “Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study”. JAMA Oncology 4.11 (2018): 1553-1568.

60 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

A novel agent attenuates cardiotoxicity and improves antitumor activity of doxorubicin in breast cancer cells.
Zhang Y, Deng H, Zhou H, Lu Y, Shan L, Lee SM, Cui G., J Cell Biochem 120(4), 2019
PMID: 30304553
Organizing palliative care in the rural areas of Iran: are family physician-based approaches suitable?
Jabbari H, Azami-Aghdash S, Piri R, Naghavi-Behzad M, Sullman MJ, Safiri S., J Pain Res 12(), 2019
PMID: 30588076
PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer.
Jiang Q, Xie M, He M, Yan F, Chen M, Xu S, Zhang X, Shen P., Medicine (Baltimore) 98(1), 2019
PMID: 30608394
Systematic review of the use of big data to improve surgery in low- and middle-income countries.
Knight SR, Ots R, Maimbo M, Drake TM, Fairfield CJ, Harrison EM., Br J Surg 106(2), 2019
PMID: 30620075
Prognostic Significance of Young Age and Non-Bone Metastasis at Diagnosis in Patients with Metastatic Prostate Cancer: a SEER Population-Based Data Analysis.
Guo Y, Mao S, Zhang A, Wang R, Zhang Z, Zhang J, Wang L, Zhang W, Wu Y, Ye L, Yang B, Yao X., J Cancer 10(3), 2019
PMID: 30719152
Surgical outcomes of two-stage hepatectomy for colorectal liver metastasis: comparison to a benchmark procedure.
Mor E, Al-Kurd A, Yaacov AB, Aderka D, Nissan A, Ariche A., Hepatobiliary Surg Nutr 8(1), 2019
PMID: 30881963
Review on gender differences in non-muscle invasive bladder cancer.
Bilski K, Zapała Ł, Skrzypczyk MA, Oszczudłowski M, Dobruch J., Transl Androl Urol 8(1), 2019
PMID: 30976563
Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study.
Liu J, Zhou H, Zhang Y, Huang Y, Fang W, Yang Y, Hong S, Chen G, Zhao S, Chen X, Zhang Z, Shen J, Xian W, Zhan J, Zhao Y, Hou X, Ma Y, Zhou T, Zhao H, Zhang L., Cancer Med 8(4), 2019
PMID: 30741477
Deep Learning Based Analysis of Histopathological Images of Breast Cancer.
Xie J, Liu R, Luttrell J, Zhang C., Front Genet 10(), 2019
PMID: 30838023
CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
Chen C, Xu ZQ, Zong YP, Ou BC, Shen XH, Feng H, Zheng MH, Zhao JK, Lu AG., Cell Death Dis 10(3), 2019
PMID: 30792394
The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again.
Hofman P, Ayache N, Barbry P, Barlaud M, Bel A, Blancou P, Checler F, Chevillard S, Cristofari G, Demory M, Esnault V, Falandry C, Gilson E, Guérin O, Glaichenhaus N, Guigay J, Ilié M, Mari B, Marquette CH, Paquis-Flucklinger V, Prate F, Saintigny P, Seitz-Polsky B, Skhiri T, Van Obberghen-Schilling E, Van Obberghen E, Yvan-Charvet L., Cancers (Basel) 11(2), 2019
PMID: 30795607
Regulation of KIF2A by Antitumor miR-451a Inhibits Cancer Cell Aggressiveness Features in Lung Squamous Cell Carcinoma.
Uchida A, Seki N, Mizuno K, Yamada Y, Misono S, Sanada H, Kikkawa N, Kumamoto T, Suetsugu T, Inoue H., Cancers (Basel) 11(2), 2019
PMID: 30813343
Mortality of lymphoma and myeloma in China, 2004-2017: an observational study.
Liu W, Liu J, Song Y, Wang X, Zhou M, Wang L, Ma J, Zhu J, Union for China Leukemia Investigators of the Chinese Society of Clinical Oncology, Union for China Lymphoma Investigators of the Chinese Society of Clinical Oncology., J Hematol Oncol 12(1), 2019
PMID: 30832702
Functionalized Large-Pore Mesoporous Silica Microparticles for Gefitinib and Doxorubicin Codelivery.
Li Y, Song F, Cheng L, Qian J, Chen Q., Materials (Basel) 12(5), 2019
PMID: 30845677
Immune cell score in pancreatic cancer-comparison of hotspot and whole-section techniques.
Tahkola K, Leppänen J, Ahtiainen M, Väyrynen J, Haapasaari KM, Karttunen T, Kellokumpu I, Helminen O, Böhm J., Virchows Arch 474(6), 2019
PMID: 30843106
Radiotherapy Exposure in Cancer Patients and Subsequent Risk of Stroke: A Systematic Review and Meta-Analysis.
Huang R, Zhou Y, Hu S, Ren G, Cui F, Zhou PK., Front Neurol 10(), 2019
PMID: 30930843
BODIPY-Decorated Nanoscale Covalent Organic Frameworks for Photodynamic Therapy.
Guan Q, Fu DD, Li YA, Kong XM, Wei ZY, Li WY, Zhang SJ, Dong YB., iScience 14(), 2019
PMID: 30981114
Radiosensitizing effect of 5-aminolevulinic acid in colorectal cancer in vitro and in vivo.
Yamada K, Murayama Y, Kamada Y, Arita T, Kosuga T, Konishi H, Morimura R, Shiozaki A, Kuriu Y, Ikoma H, Kubota T, Nakanishi M, Fujiwara H, Okamoto K, Otsuji E., Oncol Lett 17(6), 2019
PMID: 31186727
Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics.
Riobo-Del Galdo NA, Lara Montero Á, Wertheimer EV., Cells 8(4), 2019
PMID: 31027259
Population Levels Assessment of the Distribution of Disease-Associated Variants With Emphasis on Armenians - A Machine Learning Approach.
Nikoghosyan M, Hakobyan S, Hovhannisyan A, Loeffler-Wirth H, Binder H, Arakelyan A., Front Genet 10(), 2019
PMID: 31105750
Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression.
Narita S, Nara T, Sato H, Koizumi A, Huang M, Inoue T, Habuchi T., J Clin Med 8(5), 2019
PMID: 31052319
Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.
Yin X, Xu Y, Man X, Liu L, Jiang Y, Zhao L, Cheng W., Cancer Med 8(6), 2019
PMID: 31062522
A systematic review and meta-analysis on incidence of prostate cancer in Iran.
Moradi A, Zamani M, Moudi E., Health Promot Perspect 9(2), 2019
PMID: 31249795
The Role of lncRNAs in the Distant Metastasis of Breast Cancer.
Wu Y, Shao A, Wang L, Hu K, Yu C, Pan C, Zhang S., Front Oncol 9(), 2019
PMID: 31214490
Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib.
Zhang R, Chen Z, Wu SS, Xu J, Kong LC, Wei P., Med Sci Monit 25(), 2019
PMID: 31152143
Association of Anorexia Nervosa With Risk of Cancer: A Systematic Review and Meta-analysis.
Catalá-López F, Forés-Martos J, Driver JA, Page MJ, Hutton B, Ridao M, Alonso-Arroyo A, Macías Saint-Gerons D, Gènova-Maleras R, Valderas JM, Vieta E, Valencia A, Tabarés-Seisdedos R., JAMA Netw Open 2(6), 2019
PMID: 31173122
HDL and LDL: Potential New Players in Breast Cancer Development.
Cedó L, Reddy ST, Mato E, Blanco-Vaca F, Escolà-Gil JC., J Clin Med 8(6), 2019
PMID: 31208017
Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience.
Huang J, Xie X, Lin J, Wang W, Zhang X, Liu M, Li X, Huang G, Liu B, Xie X., Cancer Imaging 19(1), 2019
PMID: 31242934
A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma).
Agrawal S, Vamadevan P, Mazibuko N, Bannister R, Swery R, Wilson S, Edwards S., Front Pharmacol 10(), 2019
PMID: 31316378
Knowledge regarding breast self-examination among the women in Nepal: A meta-analysis.
Sathian B, Asim M, Mekkodathil A, James S, Mancha A, Ghosh A., Nepal J Epidemiol 9(2), 2019
PMID: 31285936
Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty.
Lordick F, Obermannova R, Vola D, Douillard JY, Mcgregor K, Van Cutsem E, Tabernero J, Ciardiello F, Cervantes A., ESMO Open 4(3), 2019
PMID: 31354964
The risk of liver cancer in autoimmune liver diseases.
Lleo A, de Boer YS, Liberal R, Colombo M., Ther Adv Med Oncol 11(), 2019
PMID: 31320937
Development of a prediction model for breast cancer based on the national cancer registry in Taiwan.
Huang CC, Chan SY, Lee WC, Chiang CJ, Lu TP, Cheng SH., Breast Cancer Res 21(1), 2019
PMID: 31409418
Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer.
Chaddad A, Kucharczyk MJ, Niazi T., Cancers (Basel) 10(8), 2018
PMID: 30060575
Improved pharmacokinetic characteristics and bioactive effects of anticancer enzyme delivery systems.
Yan S, Yang L, Lu L, Guo Q, Hu X, Yuan Y, Li Y, Wu M, Zhang J., Expert Opin Drug Metab Toxicol 14(9), 2018
PMID: 30058385
Supportive Care in Radiotherapy Based on a Mobile App: Prospective Multicenter Survey.
El Shafie RA, Weber D, Bougatf N, Sprave T, Oetzel D, Huber PE, Debus J, Nicolay NH., JMIR Mhealth Uhealth 6(8), 2018
PMID: 30166275
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.
India State-Level Disease Burden Initiative Cancer Collaborators., Lancet Oncol 19(10), 2018
PMID: 30219626
Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US.
Insinga RP, Vanness DJ, Feliciano JL, Vandormael K, Traore S, Burke T., J Med Econ 21(12), 2018
PMID: 30188231
Sulforaphane inhibits growth and blocks Wnt/β-catenin signaling of colorectal cancer cells.
Bernkopf DB, Daum G, Brückner M, Behrens J., Oncotarget 9(74), 2018
PMID: 30338040
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.
Falzone L, Salomone S, Libra M., Front Pharmacol 9(), 2018
PMID: 30483135
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells.
Sznarkowska A, Kostecka A, Kawiak A, Acedo P, Lion M, Inga A, Zawacka-Pankau J., Cell Div 13(), 2018
PMID: 30603043

38 References

Daten bereitgestellt von Europe PubMed Central.

Global effects of smoking, of quitting, and of taxing tobacco.
Jha P, Peto R., N. Engl. J. Med. 370(1), 2014
PMID: 24382066
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, Fleming T, Forouzanfar MH, Hancock J, Hay RJ, Hunter-Merrill R, Huynh C, Hosgood HD, Johnson CO, Jonas JB, Khubchandani J, Kumar GA, Kutz M, Lan Q, Larson HJ, Liang X, Lim SS, Lopez AD, MacIntyre MF, Marczak L, Marquez N, Mokdad AH, Pinho C, Pourmalek F, Salomon JA, Sanabria JR, Sandar L, Sartorius B, Schwartz SM, Shackelford KA, Shibuya K, Stanaway J, Steiner C, Sun J, Takahashi K, Vollset SE, Vos T, Wagner JA, Wang H, Westerman R, Zeeb H, Zoeckler L, Abd-Allah F, Ahmed MB, Alabed S, Alam NK, Aldhahri SF, Alem G, Alemayohu MA, Ali R, Al-Raddadi R, Amare A, Amoako Y, Artaman A, Asayesh H, Atnafu N, Awasthi A, Saleem HB, Barac A, Bedi N, Bensenor I, Berhane A, Bernabe E, Betsu B, Binagwaho A, Boneya D, Campos-Nonato I, Castaneda-Orjuela C, Catala-Lopez F, Chiang P, Chibueze C, Chitheer A, Choi JY, Cowie B, Damtew S, das Neves J, Dey S, Dharmaratne S, Dhillon P, Ding E, Driscoll T, Ekwueme D, Endries AY, Farvid M, Farzadfar F, Fernandes J, Fischer F, G/Hiwot TT, Gebru A, Gopalani S, Hailu A, Horino M, Horita N, Husseini A, Huybrechts I, Inoue M, Islami F, Jakovljevic M, James S, Javanbakht M, Jee SH, Kasaeian A, Kedir MS, Khader YS, Khang YH, Kim D, Leigh J, Linn S, Lunevicius R, El Razek HMA, Malekzadeh R, Malta DC, Marcenes W, Markos D, Melaku YA, Meles KG, Mendoza W, Mengiste DT, Meretoja TJ, Miller TR, Mohammad KA, Mohammadi A, Mohammed S, Moradi-Lakeh M, Nagel G, Nand D, Le Nguyen Q, Nolte S, Ogbo FA, Oladimeji KE, Oren E, Pa M, Park EK, Pereira DM, Plass D, Qorbani M, Radfar A, Rafay A, Rahman M, Rana SM, Soreide K, Satpathy M, Sawhney M, Sepanlou SG, Shaikh MA, She J, Shiue I, Shore HR, Shrime MG, So S, Soneji S, Stathopoulou V, Stroumpoulis K, Sufiyan MB, Sykes BL, Tabares-Seisdedos R, Tadese F, Tedla BA, Tessema GA, Thakur JS, Tran BX, Ukwaja KN, Uzochukwu BSC, Vlassov VV, Weiderpass E, Wubshet Terefe M, Yebyo HG, Yimam HH, Yonemoto N, Younis MZ, Yu C, Zaidi Z, Zaki MES, Zenebe ZM, Murray CJL, Naghavi M., JAMA Oncol 3(4), 2017
PMID: 27918777
The Global Burden of Cancer 2013.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, Hamadeh RR, Moore A, Werdecker A, Gessner BD, Te Ao B, McMahon B, Karimkhani C, Yu C, Cooke GS, Schwebel DC, Carpenter DO, Pereira DM, Nash D, Kazi DS, De Leo D, Plass D, Ukwaja KN, Thurston GD, Yun Jin K, Simard EP, Mills E, Park EK, Catala-Lopez F, deVeber G, Gotay C, Khan G, Hosgood HD 3rd, Santos IS, Leasher JL, Singh J, Leigh J, Jonas JB, Jonas J, Sanabria J, Beardsley J, Jacobsen KH, Takahashi K, Franklin RC, Ronfani L, Montico M, Naldi L, Tonelli M, Geleijnse J, Petzold M, Shrime MG, Younis M, Yonemoto N, Breitborde N, Yip P, Pourmalek F, Lotufo PA, Esteghamati A, Hankey GJ, Ali R, Lunevicius R, Malekzadeh R, Dellavalle R, Weintraub R, Lucas R, Hay R, Rojas-Rueda D, Westerman R, Sepanlou SG, Nolte S, Patten S, Weichenthal S, Abera SF, Fereshtehnejad SM, Shiue I, Driscoll T, Vasankari T, Alsharif U, Rahimi-Movaghar V, Vlassov VV, Marcenes WS, Mekonnen W, Melaku YA, Yano Y, Artaman A, Campos I, MacLachlan J, Mueller U, Kim D, Trillini M, Eshrati B, Williams HC, Shibuya K, Dandona R, Murthy K, Cowie B, Amare AT, Antonio CA, Castaneda-Orjuela C, van Gool CH, Violante F, Oh IH, Deribe K, Soreide K, Knibbs L, Kereselidze M, Green M, Cardenas R, Roy N, Tillmann T, Tillman T, Li Y, Krueger H, Monasta L, Dey S, Sheikhbahaei S, Hafezi-Nejad N, Kumar GA, Sreeramareddy CT, Dandona L, Wang H, Vollset SE, Mokdad A, Salomon JA, Lozano R, Vos T, Forouzanfar M, Lopez A, Murray C, Naghavi M., JAMA Oncol 1(4), 2015
PMID: 26181261
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.
Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L., N. Engl. J. Med. 375(7), 2016
PMID: 27532827
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, Artaman A, Ayele TA, Barac A, Bensenor I, Berhane A, Bhutta Z, Castillo-Rivas J, Chitheer A, Choi JY, Cowie B, Dandona L, Dandona R, Dey S, Dicker D, Phuc H, Ekwueme DU, Zaki MS, Fischer F, Furst T, Hancock J, Hay SI, Hotez P, Jee SH, Kasaeian A, Khader Y, Khang YH, Kumar A, Kutz M, Larson H, Lopez A, Lunevicius R, Malekzadeh R, McAlinden C, Meier T, Mendoza W, Mokdad A, Moradi-Lakeh M, Nagel G, Nguyen Q, Nguyen G, Ogbo F, Patton G, Pereira DM, Pourmalek F, Qorbani M, Radfar A, Roshandel G, Salomon JA, Sanabria J, Sartorius B, Satpathy M, Sawhney M, Sepanlou S, Shackelford K, Shore H, Sun J, Mengistu DT, Topor-Madry R, Tran B, Ukwaja , Vlassov V, Vollset SE, Vos T, Wakayo T, Weiderpass E, Werdecker A, Yonemoto N, Younis M, Yu C, Zaidi Z, Zhu L, Murray CJL, Naghavi M, Fitzmaurice C., JAMA Oncol 3(12), 2017
PMID: 28983565
Saving the World's Women from Cervical Cancer.
Tsu V, Jeronimo J., N. Engl. J. Med. 374(26), 2016
PMID: 27355529
Offline: NCDs-why are we failing?
Horton R., Lancet 390(10092), 2017
PMID: 28745593
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM, Anderson RN, Ma J, Ly KN, Cronin KA, Penberthy L, Kohler BA., Cancer 122(9), 2016
PMID: 26959385
Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F., Eur. J. Cancer 49(15), 2013
PMID: 23751569
Cancer incidence and mortality attributable to alcohol consumption.
Praud D, Rota M, Rehm J, Shield K, Zatonski W, Hashibe M, La Vecchia C, Boffetta P., Int. J. Cancer 138(6), 2015
PMID: 26455822
Modeling causes of death: an integrated approach using CODEm.
Foreman KJ, Lozano R, Lopez AD, Murray CJ., Popul Health Metr 10(), 2012
PMID: 22226226
Global effects of smoking, of quitting, and of taxing tobacco.
Jha P, Peto R., N. Engl. J. Med. 370(1), 2014
PMID: 24382066
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, Fleming T, Forouzanfar MH, Hancock J, Hay RJ, Hunter-Merrill R, Huynh C, Hosgood HD, Johnson CO, Jonas JB, Khubchandani J, Kumar GA, Kutz M, Lan Q, Larson HJ, Liang X, Lim SS, Lopez AD, MacIntyre MF, Marczak L, Marquez N, Mokdad AH, Pinho C, Pourmalek F, Salomon JA, Sanabria JR, Sandar L, Sartorius B, Schwartz SM, Shackelford KA, Shibuya K, Stanaway J, Steiner C, Sun J, Takahashi K, Vollset SE, Vos T, Wagner JA, Wang H, Westerman R, Zeeb H, Zoeckler L, Abd-Allah F, Ahmed MB, Alabed S, Alam NK, Aldhahri SF, Alem G, Alemayohu MA, Ali R, Al-Raddadi R, Amare A, Amoako Y, Artaman A, Asayesh H, Atnafu N, Awasthi A, Saleem HB, Barac A, Bedi N, Bensenor I, Berhane A, Bernabe E, Betsu B, Binagwaho A, Boneya D, Campos-Nonato I, Castaneda-Orjuela C, Catala-Lopez F, Chiang P, Chibueze C, Chitheer A, Choi JY, Cowie B, Damtew S, das Neves J, Dey S, Dharmaratne S, Dhillon P, Ding E, Driscoll T, Ekwueme D, Endries AY, Farvid M, Farzadfar F, Fernandes J, Fischer F, G/Hiwot TT, Gebru A, Gopalani S, Hailu A, Horino M, Horita N, Husseini A, Huybrechts I, Inoue M, Islami F, Jakovljevic M, James S, Javanbakht M, Jee SH, Kasaeian A, Kedir MS, Khader YS, Khang YH, Kim D, Leigh J, Linn S, Lunevicius R, El Razek HMA, Malekzadeh R, Malta DC, Marcenes W, Markos D, Melaku YA, Meles KG, Mendoza W, Mengiste DT, Meretoja TJ, Miller TR, Mohammad KA, Mohammadi A, Mohammed S, Moradi-Lakeh M, Nagel G, Nand D, Le Nguyen Q, Nolte S, Ogbo FA, Oladimeji KE, Oren E, Pa M, Park EK, Pereira DM, Plass D, Qorbani M, Radfar A, Rafay A, Rahman M, Rana SM, Soreide K, Satpathy M, Sawhney M, Sepanlou SG, Shaikh MA, She J, Shiue I, Shore HR, Shrime MG, So S, Soneji S, Stathopoulou V, Stroumpoulis K, Sufiyan MB, Sykes BL, Tabares-Seisdedos R, Tadese F, Tedla BA, Tessema GA, Thakur JS, Tran BX, Ukwaja KN, Uzochukwu BSC, Vlassov VV, Weiderpass E, Wubshet Terefe M, Yebyo HG, Yimam HH, Yonemoto N, Younis MZ, Yu C, Zaidi Z, Zaki MES, Zenebe ZM, Murray CJL, Naghavi M., JAMA Oncol 3(4), 2017
PMID: 27918777
The Global Burden of Cancer 2013.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, Hamadeh RR, Moore A, Werdecker A, Gessner BD, Te Ao B, McMahon B, Karimkhani C, Yu C, Cooke GS, Schwebel DC, Carpenter DO, Pereira DM, Nash D, Kazi DS, De Leo D, Plass D, Ukwaja KN, Thurston GD, Yun Jin K, Simard EP, Mills E, Park EK, Catala-Lopez F, deVeber G, Gotay C, Khan G, Hosgood HD 3rd, Santos IS, Leasher JL, Singh J, Leigh J, Jonas JB, Jonas J, Sanabria J, Beardsley J, Jacobsen KH, Takahashi K, Franklin RC, Ronfani L, Montico M, Naldi L, Tonelli M, Geleijnse J, Petzold M, Shrime MG, Younis M, Yonemoto N, Breitborde N, Yip P, Pourmalek F, Lotufo PA, Esteghamati A, Hankey GJ, Ali R, Lunevicius R, Malekzadeh R, Dellavalle R, Weintraub R, Lucas R, Hay R, Rojas-Rueda D, Westerman R, Sepanlou SG, Nolte S, Patten S, Weichenthal S, Abera SF, Fereshtehnejad SM, Shiue I, Driscoll T, Vasankari T, Alsharif U, Rahimi-Movaghar V, Vlassov VV, Marcenes WS, Mekonnen W, Melaku YA, Yano Y, Artaman A, Campos I, MacLachlan J, Mueller U, Kim D, Trillini M, Eshrati B, Williams HC, Shibuya K, Dandona R, Murthy K, Cowie B, Amare AT, Antonio CA, Castaneda-Orjuela C, van Gool CH, Violante F, Oh IH, Deribe K, Soreide K, Knibbs L, Kereselidze M, Green M, Cardenas R, Roy N, Tillmann T, Tillman T, Li Y, Krueger H, Monasta L, Dey S, Sheikhbahaei S, Hafezi-Nejad N, Kumar GA, Sreeramareddy CT, Dandona L, Wang H, Vollset SE, Mokdad A, Salomon JA, Lozano R, Vos T, Forouzanfar M, Lopez A, Murray C, Naghavi M., JAMA Oncol 1(4), 2015
PMID: 26181261
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.
Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L., N. Engl. J. Med. 375(7), 2016
PMID: 27532827
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, Artaman A, Ayele TA, Barac A, Bensenor I, Berhane A, Bhutta Z, Castillo-Rivas J, Chitheer A, Choi JY, Cowie B, Dandona L, Dandona R, Dey S, Dicker D, Phuc H, Ekwueme DU, Zaki MS, Fischer F, Furst T, Hancock J, Hay SI, Hotez P, Jee SH, Kasaeian A, Khader Y, Khang YH, Kumar A, Kutz M, Larson H, Lopez A, Lunevicius R, Malekzadeh R, McAlinden C, Meier T, Mendoza W, Mokdad A, Moradi-Lakeh M, Nagel G, Nguyen Q, Nguyen G, Ogbo F, Patton G, Pereira DM, Pourmalek F, Qorbani M, Radfar A, Roshandel G, Salomon JA, Sanabria J, Sartorius B, Satpathy M, Sawhney M, Sepanlou S, Shackelford K, Shore H, Sun J, Mengistu DT, Topor-Madry R, Tran B, Ukwaja , Vlassov V, Vollset SE, Vos T, Wakayo T, Weiderpass E, Werdecker A, Yonemoto N, Younis M, Yu C, Zaidi Z, Zhu L, Murray CJL, Naghavi M, Fitzmaurice C., JAMA Oncol 3(12), 2017
PMID: 28983565
Saving the World's Women from Cervical Cancer.
Tsu V, Jeronimo J., N. Engl. J. Med. 374(26), 2016
PMID: 27355529
Offline: NCDs-why are we failing?
Horton R., Lancet 390(10092), 2017
PMID: 28745593
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM, Anderson RN, Ma J, Ly KN, Cronin KA, Penberthy L, Kohler BA., Cancer 122(9), 2016
PMID: 26959385
Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F., Eur. J. Cancer 49(15), 2013
PMID: 23751569
Cancer incidence and mortality attributable to alcohol consumption.
Praud D, Rota M, Rehm J, Shield K, Zatonski W, Hashibe M, La Vecchia C, Boffetta P., Int. J. Cancer 138(6), 2015
PMID: 26455822
Modeling causes of death: an integrated approach using CODEm.
Foreman KJ, Lozano R, Lopez AD, Murray CJ., Popul Health Metr 10(), 2012
PMID: 22226226
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 29860482
PubMed | Europe PMC

Suchen in

Google Scholar